COVID-19 and Recurrent Venous Thromboembolism (CORE-VTE).
Given the prolonged follow-up period off anticoagulant treatment for most patients, it is reasonable to consider 3-6 months of therapy for COVID-19-associated VTE.
Authors
- Micheal Guirguis (ORCID: https://orcid.org/0000-0002-8858-3129)
- Timothy En Haw Chan (ORCID: https://orcid.org/0000-0002-2456-9336)
- Xueyi Chen (ORCID: https://orcid.org/0000-0001-9869-6701)
- Jan Clarkson (ORCID: https://orcid.org/0000-0001-5940-2926)
- Tammy J. Bungard (ORCID: https://orcid.org/0000-0003-1805-5715)
- Priya Samuel
Institutions
- Alberta Health Services (CA)
- University of Alberta (CA)
- Alberta Health (CA)
Publication Details
- Journal
- PubMed
- Published
- 2025-01-01
- DOI
- https://doi.org/10.4212/cjhp.3702
- Primary Topic
- Venous Thromboembolism Diagnosis and Management
- Type
- article
- Field-Weighted Citation Impact
- 0.00